These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
209 related articles for article (PubMed ID: 29859924)
1. Chitosan based polymer-lipid hybrid nanoparticles for oral delivery of enoxaparin. Dong W; Wang X; Liu C; Zhang X; Zhang X; Chen X; Kou Y; Mao S Int J Pharm; 2018 Aug; 547(1-2):499-505. PubMed ID: 29859924 [TBL] [Abstract][Full Text] [Related]
2. In vitro and in vivo evaluation of chitosan graft glyceryl monooleate as peroral delivery carrier of enoxaparin. Wang L; Li L; Sun Y; Ding J; Li J; Duan X; Li Y; Junyaprasert VB; Mao S Int J Pharm; 2014 Aug; 471(1-2):391-9. PubMed ID: 24882036 [TBL] [Abstract][Full Text] [Related]
3. Exploration of hydrophobic modification degree of chitosan-based nanocomplexes on the oral delivery of enoxaparin. Wang L; Li L; Sun Y; Tian Y; Li Y; Li C; Junyaprasert VB; Mao S Eur J Pharm Sci; 2013 Nov; 50(3-4):263-71. PubMed ID: 23896170 [TBL] [Abstract][Full Text] [Related]
4. Alginate coated chitosan core shell nanoparticles for oral delivery of enoxaparin: in vitro and in vivo assessment. Bagre AP; Jain K; Jain NK Int J Pharm; 2013 Nov; 456(1):31-40. PubMed ID: 23994363 [TBL] [Abstract][Full Text] [Related]
5. Uptake, transport and peroral absorption of fatty glyceride grafted chitosan copolymer-enoxaparin nanocomplexes: influence of glyceride chain length. Wang L; Sun Y; Shi C; Li L; Guan J; Zhang X; Ni R; Duan X; Li Y; Mao S Acta Biomater; 2014 Aug; 10(8):3675-85. PubMed ID: 24814881 [TBL] [Abstract][Full Text] [Related]
6. Bioadhesion and oral absorption of enoxaparin nanocomplexes. Sun W; Mao S; Wang Y; Junyaprasert VB; Zhang T; Na L; Wang J Int J Pharm; 2010 Feb; 386(1-2):275-81. PubMed ID: 19958824 [TBL] [Abstract][Full Text] [Related]
7. Gastrointestinal stability, physicochemical characterization and oral bioavailability of chitosan or its derivative-modified solid lipid nanoparticles loading docetaxel. Shi LL; Lu J; Cao Y; Liu JY; Zhang XX; Zhang H; Cui JH; Cao QR Drug Dev Ind Pharm; 2017 May; 43(5):839-846. PubMed ID: 27487431 [TBL] [Abstract][Full Text] [Related]
8. Development and characterization of polymer lipid hybrid nanoparticles for oral delivery of LMWH. Hallan SS; Kaur V; Jain V; Mishra N Artif Cells Nanomed Biotechnol; 2017 Dec; 45(8):1631-1639. PubMed ID: 28071140 [TBL] [Abstract][Full Text] [Related]
9. Chitosan nanoconstructs for improved oral delivery of low molecular weight heparin: In vitro and in vivo evaluation. Paliwal R; Paliwal SR; Agrawal GP; Vyas SP Int J Pharm; 2012 Jan; 422(1-2):179-84. PubMed ID: 22079712 [TBL] [Abstract][Full Text] [Related]
10. Chitosan-functionalized lipid-polymer hybrid nanoparticles for oral delivery of silymarin and enhanced lipid-lowering effect in NAFLD. Liang J; Liu Y; Liu J; Li Z; Fan Q; Jiang Z; Yan F; Wang Z; Huang P; Feng N J Nanobiotechnology; 2018 Sep; 16(1):64. PubMed ID: 30176941 [TBL] [Abstract][Full Text] [Related]
11. Improved oral delivery of resveratrol from N-trimethyl chitosan-g-palmitic acid surface-modified solid lipid nanoparticles. Ramalingam P; Ko YT Colloids Surf B Biointerfaces; 2016 Mar; 139():52-61. PubMed ID: 26700233 [TBL] [Abstract][Full Text] [Related]
12. Self-assembled polyelectrolyte nanocomplexes between chitosan derivatives and enoxaparin. Sun W; Mao S; Mei D; Kissel T Eur J Pharm Biopharm; 2008 Jun; 69(2):417-25. PubMed ID: 18294825 [TBL] [Abstract][Full Text] [Related]
13. Synthesis of Eudragit® L100-coated chitosan-based nanoparticles for oral enoxaparin delivery. Patriota YBG; Arruda IES; de Jesus Oliveira AC; de Oliveira TC; de Lemos Vasconcelos Silva E; Chaves LL; de Oliveira Silva Ribeiro F; da Silva DA; de La Roca Soares MF; Soares-Sobrinho JL Int J Biol Macromol; 2021 Dec; 193(Pt A):450-456. PubMed ID: 34688680 [TBL] [Abstract][Full Text] [Related]
14. Fabrication of novel GMO/Eudragit E100 nanostructures for enhancing oral bioavailability of carvedilol. Patil SS; Roy K; Choudhary B; Mahadik KR Drug Dev Ind Pharm; 2016 Aug; 42(8):1300-7. PubMed ID: 26651381 [TBL] [Abstract][Full Text] [Related]
15. Effects of PEGylated lipid nanoparticles on the oral absorption of one BCS II drug: a mechanistic investigation. Zhang X; Chen G; Zhang T; Ma Z; Wu B Int J Nanomedicine; 2014; 9():5503-14. PubMed ID: 25473287 [TBL] [Abstract][Full Text] [Related]
16. pH-responsive thiolated chitosan nanoparticles for oral low-molecular weight heparin delivery: in vitro and in vivo evaluation. Fan B; Xing Y; Zheng Y; Sun C; Liang G Drug Deliv; 2016; 23(1):238-47. PubMed ID: 24865290 [TBL] [Abstract][Full Text] [Related]
17. Enhanced oral insulin delivery via surface hydrophilic modification of chitosan copolymer based self-assembly polyelectrolyte nanocomplex. Liu C; Kou Y; Zhang X; Dong W; Cheng H; Mao S Int J Pharm; 2019 Jan; 554():36-47. PubMed ID: 30385377 [TBL] [Abstract][Full Text] [Related]
18. A Comprehensive Physicochemical, In Vitro and Molecular Characterization of Letrozole Incorporated Chitosan-Lipid Nanocomplex. Azandaryani AH; Kashanian S; Shahlaei M; Derakhshandeh K; Motiei M; Moradi S Pharm Res; 2019 Mar; 36(4):62. PubMed ID: 30850895 [TBL] [Abstract][Full Text] [Related]
19. Gelatin coated hybrid lipid nanoparticles for oral delivery of amphotericin B. Jain S; Valvi PU; Swarnakar NK; Thanki K Mol Pharm; 2012 Sep; 9(9):2542-53. PubMed ID: 22845020 [TBL] [Abstract][Full Text] [Related]
20. Lipid polymer hybrid as emerging tool in nanocarriers for oral drug delivery. Hallan SS; Kaur P; Kaur V; Mishra N; Vaidya B Artif Cells Nanomed Biotechnol; 2016; 44(1):334-49. PubMed ID: 25237838 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]